| Document |
Document Title |
|
WO/2019/071039A1 |
The present disclosure provides systems and methods for making a hydrogel comprising a cell, cell nucleus, or one or more components derived from a cell or cell nucleus. A method for making a hydrogel may comprise providing a cell or cel...
|
|
WO/2019/070992A1 |
Metastable state spore incubation mixing systems are described. An example system includes a spore container to store spores, a nutrient container, an arrangement of valves and tubes, a reciprocating pump, a mixing tube, and a holding ta...
|
|
WO/2019/069809A1 |
Provided is a carrier, etc., for protein immobilization with which it is possible to adequately manifest the activity of the immobilized protein. A carrier for protein immobilization for immobilizing the amino groups of a protein, the ca...
|
|
WO/2019/059624A2 |
The present invention relates to a composition for in vitro production of trans-resveratrol, the composition comprising purified photosynthetic membrane vesicles and a trans-resveratrol biosynthesis-related enzyme, and to a production me...
|
|
WO/2019/057914A1 |
The present invention relates to a composition comprising a continuous aqueous phase and at least one capsule, said capsule comprising a core, which is liquid or at least partly gelled or at least partly thixotropic, and at least one out...
|
|
WO/2019/057958A1 |
The present invention relates to polymeric particles comprising a biodegradable polymer, and at least one microorganism in a total concentration of at least 108 CFU/g dry weight that is stable for at least 35 weeks at 30°C and optionall...
|
|
WO/2019/050389A1 |
The present invention relates to a method of producing an article suitable for use as a bioflocculant or a biosorbent for waste material and heavy metal removal. The method preferably comprises the steps of growing cells of a marine fila...
|
|
WO/2019/050978A1 |
Disclosed herein are compositions and methods for preparation and use of protein therapeutics, and more particularly protein clusters or backpacks having a plurality of therapeutic protein monomers reversibly crossed-linked by biodegrada...
|
|
WO/2019/039777A1 |
The present invention relates to a porous silica carrier for stabilizing proteins and enzymes, and a production method and use thereof. A silica carrier according to the present invention is harmless to the human body, is based on silica...
|
|
WO/2019/028666A1 |
Disclosed is a method for preparing levetiracetam, comprising the following steps: performing resolution under the action of an ester hydrolase using 2-halobutyrate as a raw material to obtain (S)-2-halobutyrate, reacting with 2-pyrrolid...
|
|
WO/2019/023555A1 |
Provided herein are methods and compositions related to polymer-coated bacteria.
|
|
WO/2019/021274A1 |
The present invention provides polynucleotide constructs with at least one disruption or tearing responsive promoter and at least one sequence encoding a fiber-forming protein. The invention further provides a cell comprising such a cons...
|
|
WO/2019/013100A1 |
Provided is a composite composition which is capable of stabilizing biomolecules. A composite composition according to one embodiment of the present invention contains biomolecules and anion-modified cellulose nanofibers that have a cell...
|
|
WO/2019/014178A1 |
Various embodiments of the present technology provide methods and systems for soil enrichment. The systems may comprise a bioreactor system coupled to an initial treatment system for the cultivation of a live microorganism culture contai...
|
|
WO/2019/006908A1 |
A nanometer photocatalyst-microbe composite multilayer light transmission combination carrier, comprising a plurality of wave-shaped organic glass plates (1), a serial rod fixing rack (4), middle-through elastic spacers (5), and fixing s...
|
|
WO/2019/004446A1 |
The present invention addresses the problem of providing an excellent treatment agent for lysosomal storage disease. Provided is a treatment agent for lysosomal storage disease, containing a cellular structure that includes multiple bioc...
|
|
WO/2019/006077A1 |
Described are compositions and methods relating to low density enzyme-containing particles for inclusion in cleaning and other low-water compositions. The particles remain in suspension without settling, and release active enzyme upon di...
|
|
WO/2019/002658A3 |
The present invention relates to a method for the enzymatic synthesis of long-chain fatty acid alkyl esters in the presence of an alcohol and of an enzymatic preparation comprising a sterol esterase/lipase immobilised covalently on surfa...
|
|
WO/2018/233197A1 |
A low GI brown sugar and a preparation method therefor. A sucrose isomerase and a glucose isomerase are immobilized on bagasse biochar at a certain ratio to form a bagasse biochar immobilized enzyme, and cane juice is transformed by the ...
|
|
WO/2018/227644A1 |
Provided is a method for catalyzing steroidal biological transformation. In the method, sodium alginate-grafted cyclodextrin immobilized cells are used as a catalyst, so as to implement the cyclic utilization of a cyclodextrin medium, th...
|
|
WO/2018/231704A1 |
Provided herein are processes for the preparation 6-bromonicotinamide.
|
|
WO/2018/231704A8 |
Provided herein are processes for the preparation 6-bromonicotinamide.
|
|
WO/2018/226901A1 |
A living tissue model device includes: a first liquid compartment storing a liquid composition; a second liquid compartment storing a liquid composition; and a cell layered body disposed between the first liquid compartment and the secon...
|
|
WO/2018/221823A1 |
The present invention relates to a preparation method of a matrix of rice husk silica for immobilizing enzyme wherein a rice husk silica is modified with APTES((3-aminopropyl)triethoxysilane) and glutaraldehyde, a matrix of rice husk sil...
|
|
WO/2018/211990A1 |
Provided is a method for delivering a protein from a solid support to cells, the method including (1) a step for preparing a composite containing the protein and a cationic polymer, (2) a step for immobilizing the complex on the solid su...
|
|
WO/2018/212095A1 |
[Problem] To provide: a β-1,6-glucanase mutant having a specific binding activity to β-1,6-glucan; and a method for measuring β-1,6-glucan using the β-1,6-glucanase mutant. [Solution] A β-1,6-glucanase mutant which is a mutant of β...
|
|
WO/2018/208726A1 |
Methods and systems are directed to multiplex detection of a bacterial pathogen in a sample. A first biotinylated lysin-derived cell wall binding domain is complexed with an avidin layer on a surface. A first bacterial pathogen detection...
|
|
WO/2018/204627A1 |
Multi-use biosensors are disclosed that include enzymes that have been modified to reduce the solubility thereof; the multi-use biosensors are used to detect analytes in fluidic biological samples, and the biosensors also maintain their ...
|
|
WO/2018/204439A1 |
Nano-sized delivery vehicles utilize carbon nanotubes (CNTs) for the generic, targeted and passive transport of biomolecules into plant cells.
|
|
WO/2018/204854A1 |
Methods and kits for preparing re-usable single cells are described. Cell components are anchored using a nano-scale scaffold to create a re-usable single cell. The nano-scale scaffold may be a polyacrylamide nano-scale scaffold. Methods...
|
|
WO/2018/201098A2 |
A membrane structure for moving a gaseous object species from a first region having an object species first concentration, through the membrane structure, to a second region having an object species second concentration different from th...
|
|
WO/2018/201098A3 |
A membrane structure for moving a gaseous object species from a first region having an object species first concentration, through the membrane structure, to a second region having an object species second concentration different from th...
|
|
WO/2018/201160A1 |
The present disclosure relates to compositions of immobilized enzymes on the surface of achromosomal and/or anucleate cells and uses thereof. In particular, the present disclosure provides genetically engineered minicells with enzymes se...
|
|
WO/2018/195279A1 |
Embodiments described herein generally relate to systems and methods for processing non-fermented liquids. In some embodiments, non-fermented liquids may be processed into fermentable liquids in relatively short time (e.g., less than or ...
|
|
WO/2018/191244A1 |
Described herein are preparations and applications of gellan gum hydrogel for cell culture and biomedical applications, including 2D coating culture, 3D cell culture, and injection. The gellan gum materials for such application include w...
|
|
WO/2018/191701A1 |
Provided herein are methods for screening biological functions of microscale biological systems comprises segregating each microscale biological system from a set of microscale biological systems to be screened into individual discrete v...
|
|
WO/2018/187752A1 |
Provided herein are methods for the controlled, independent modification of the surface of titanium-based materials and compositions generated thereby. The methods allow for the alteration of multiple surface characteristics including ge...
|
|
WO/2018/186185A1 |
This cell cultivation method includes a step in which kidney cells 24 are cultivated in an unadhered condition in a culture vessel 26 for a period of five days or more, an aggregate 30 of the kidney cells 24 is formed during the cultivat...
|
|
WO/2018/174748A1 |
The invention relates to the field of biotechnology and pharmaceutics. Proposed is a method for ultra-high performance screening of biological objects which is based on microfluidic generation of droplets of a biocompatible water-in-oil-...
|
|
WO/2018/169972A1 |
Genetically modified microorganisms that have the ability to convert carbon substrates into chemical products such as 1,4-BDO are disclosed. For example, genetically modified methanotrophs that are capable of generating 1,4-BDO at high t...
|
|
WO/2018/161631A1 |
An enzymatic deacidification method for partial glyceride lipase and PUFA-rich oil, comprising the following steps: 1) mixing a polyunsaturated fatty acid (PUFA)-rich oil with a non-polar organic solvent and a short-chain monohydric alco...
|
|
WO/2018/160908A1 |
The present disclosure provides technologies for modulating gene expression.
|
|
WO/2018/159797A1 |
The present invention addresses the problem of providing: an embedding agent for a cell mass or a cell structure which allows the cell mass or the cell structure to be stably transported during transportation at low temperature, and allo...
|
|
WO/2018/155622A1 |
By suppressing the loss of living cells or living tissue during the production of a PVA gel that contains living cells or living tissue, the present invention addresses the problem of supplying a cell- or tissue-embedding device that has...
|
|
WO/2018/151186A1 |
The present invention provides a bead containing a polymer that contains a uronic acid unit having a mercapto group, wherein all or a portion of the mercapto group forms a disulfide bond.
|
|
WO/2018/151423A1 |
The present invention relates to: transparent disk-shaped microparticles surface-modified with polydopamine; and cell culturing using the same. When cells are cultured using disk-shaped microparticles coated with polydopamine according t...
|
|
WO/2018/147630A1 |
The present invention relates to a method for producing a virus by a semi-continuous culture method and a method for mass-producing a fish virus at a high concentration by using a cell line attached to a microcarrier, which overcomes com...
|
|
WO/2018/148054A1 |
A nanobiocatalytic membrane for a filtration system is provided which includes a filtration membrane and a plurality of nanobiocatalyst nanoparticles associated with the membrane, each of the nanobiocatalyst nanoparticles including a cor...
|
|
WO/2018/141071A1 |
The present invention relates to products and method of preparing and using surface modified polymeric material having siliceous particles deposited thereon. The method and article are disclosed wherein a plastic substrate is provided wi...
|
|
WO/2018/144686A1 |
A method for obtaining grey water excreta includes reducing ammonia content of the liquid fraction in a first porous medium in which the ammonia content is decomposed, and reducing the byproducts in a second batch of similar porous mediu...
|
